The BioCentury Report on Industry Trends covers how companies and academic investigators are driving innovations within immuno-oncology, including new targets, modalities and technologies, to address some of the field's biggest challenges. Some topics include:

The broadening trend to harness the innate and adaptive arms of the immune system for immunotherapies
New cell types beyond CAR-T and traditional T-cells
Combination strategies for neoantigens and other targets from the earliest stages of drug development

This presentation, presented by Simone Fishburn, PhD, Editor, BioCentury Innovations, was given at the 4th Annual Immuno-Oncology 360° Event on February 7-9, 2018 in New York City.

Find more information at io360summit.com

The BioCentury Report on Immuno-Oncology Industry Trends

Share

Embed